Immunohistochemical detection of DNA topoisomerase IIalpha, P-glycoprotein and multidrug resistance protein (MRP) in small-cell and non-small-cell lung cancer.

Non-small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC) differ significantly in their clinical response to topoisomerase IIalpha (topo-IIalpha)-directed drugs, such as etoposide and teniposide, as NSCLC is virtually insensitive to single-agent therapy, while SCLC responds in two-thirds...

Descripción completa

Detalles Bibliográficos
Autores principales: Kreisholt, J., Sorensen, M., Jensen, P. B., Nielsen, B. S., Andersen, C. B., Sehested, M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150192/
https://www.ncbi.nlm.nih.gov/pubmed/9652763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150192/
https://www.ncbi.nlm.nih.gov/pubmed/9652763

Ejemplares similares